749 lines
20 KiB
Markdown
749 lines
20 KiB
Markdown
# Research Poster Content Guide
|
|
|
|
## Overview
|
|
|
|
Content is king in research posters. This guide covers writing strategies, section-specific guidance, visual-text balance, and best practices for communicating research effectively in poster format.
|
|
|
|
## Core Content Principles
|
|
|
|
### 1. The 3-5 Minute Rule
|
|
|
|
**Reality**: Most viewers spend 3-5 minutes at your poster
|
|
- **1 minute**: Scanning from distance (title, figures)
|
|
- **2-4 minutes**: Reading key points up close
|
|
- **5+ minutes**: Engaged conversation (if interested)
|
|
|
|
**Design Implication**: Poster must work at three levels:
|
|
1. **Distance view** (6-10 feet): Title and main figure visible
|
|
2. **Browse view** (3-6 feet): Section headers and key results readable
|
|
3. **Detail view** (1-3 feet): Full content accessible
|
|
|
|
### 2. Tell a Story, Not a Paper
|
|
|
|
**Poster ≠ Condensed Paper**
|
|
|
|
**Paper approach** (❌):
|
|
- Comprehensive literature review
|
|
- Detailed methodology
|
|
- All results presented
|
|
- Lengthy discussion
|
|
- 50+ references
|
|
|
|
**Poster approach** (✅):
|
|
- One sentence background
|
|
- Visual methods diagram
|
|
- 3-5 key results
|
|
- 3-4 bullet point conclusions
|
|
- 5-10 key references
|
|
|
|
**Story Arc for Posters**:
|
|
```
|
|
Hook (Problem) → Approach → Discovery → Impact
|
|
```
|
|
|
|
**Example**:
|
|
- **Hook**: "Antibiotic resistance threatens millions of lives annually"
|
|
- **Approach**: "We developed an AI system to predict resistance patterns"
|
|
- **Discovery**: "Our model achieves 87% accuracy, 20% better than existing methods"
|
|
- **Impact**: "Could reduce treatment failures by identifying resistance earlier"
|
|
|
|
### 3. The 800-Word Maximum
|
|
|
|
**Word Count Guidelines**:
|
|
- **Ideal**: 300-500 words
|
|
- **Maximum**: 800 words
|
|
- **Hard limit**: 1000 words (beyond this, poster is unreadable)
|
|
|
|
**Word Budget by Section**:
|
|
| Section | Word Count | % of Total |
|
|
|---------|-----------|------------|
|
|
| Introduction/Background | 50-100 | 15% |
|
|
| Methods | 100-150 | 25% |
|
|
| Results (text) | 100-200 | 25% |
|
|
| Discussion/Conclusions | 100-150 | 25% |
|
|
| References/Acknowledgments | 50-100 | 10% |
|
|
|
|
**Counting Tool**:
|
|
```latex
|
|
% Add word count to poster (remove for final)
|
|
\usepackage{texcount}
|
|
% Compile with: texcount -inc poster.tex
|
|
```
|
|
|
|
### 4. Visual-to-Text Ratio
|
|
|
|
**Optimal Balance**: 40-50% visual content, 50-60% text+white space
|
|
|
|
**Visual Content Includes**:
|
|
- Figures and graphs
|
|
- Photos and images
|
|
- Diagrams and flowcharts
|
|
- Icons and symbols
|
|
- Color blocks and design elements
|
|
|
|
**Too Text-Heavy** (❌):
|
|
- Wall of text
|
|
- Small figures
|
|
- Intimidating to viewers
|
|
- Low engagement
|
|
|
|
**Well-Balanced** (✅):
|
|
- Clear figures dominate
|
|
- Text supports visuals
|
|
- Easy to scan
|
|
- Inviting appearance
|
|
|
|
## Section-Specific Content Guidance
|
|
|
|
### Title
|
|
|
|
**Purpose**: Capture attention, convey topic, establish credibility
|
|
|
|
**Characteristics of Effective Titles**:
|
|
- **Concise**: 10-15 words maximum
|
|
- **Descriptive**: Clearly states research topic
|
|
- **Active**: Uses strong verbs when possible
|
|
- **Specific**: Avoids vague terms
|
|
- **Jargon-aware**: Balances field-specific terms with accessibility
|
|
|
|
**Title Formulas**:
|
|
|
|
**1. Descriptive**:
|
|
```
|
|
[Method/Approach] for [Problem/Application]
|
|
|
|
Example: "Deep Learning for Early Detection of Alzheimer's Disease"
|
|
```
|
|
|
|
**2. Question**:
|
|
```
|
|
[Research Question]?
|
|
|
|
Example: "Can Microbiome Diversity Predict Treatment Response?"
|
|
```
|
|
|
|
**3. Assertion**:
|
|
```
|
|
[Finding] in [Context]
|
|
|
|
Example: "Novel Mechanism Identified in Drug Resistance Pathways"
|
|
```
|
|
|
|
**4. Colon Format**:
|
|
```
|
|
[Topic]: [Specific Approach/Finding]
|
|
|
|
Example: "Urban Heat Islands: A Machine Learning Framework for Mitigation"
|
|
```
|
|
|
|
**Avoid**:
|
|
- ❌ Generic titles: "A Study of X"
|
|
- ❌ Overly cute or clever wordplay (confuses message)
|
|
- ❌ Excessive jargon: "Utilization of CRISPR-Cas9..."
|
|
- ❌ Unnecessarily long: "Investigation of the potential role of..."
|
|
|
|
**LaTeX Title Formatting**:
|
|
```latex
|
|
% Emphasize key words with bold
|
|
\title{Deep Learning for \textbf{Early Detection} of Alzheimer's Disease}
|
|
|
|
% Two-line titles for long names
|
|
\title{Machine Learning Framework for\\Urban Heat Island Mitigation}
|
|
|
|
% Avoid ALL CAPS (harder to read)
|
|
```
|
|
|
|
### Authors and Affiliations
|
|
|
|
**Best Practices**:
|
|
- **Presenting author**: Bold, underline, or asterisk
|
|
- **Corresponding author**: Include email
|
|
- **Affiliations**: Superscript numbers or symbols
|
|
- **Institutional logos**: 2-4 maximum
|
|
|
|
**Format Examples**:
|
|
```latex
|
|
% Simple format
|
|
\author{\textbf{Jane Smith}\textsuperscript{1}, John Doe\textsuperscript{2}}
|
|
\institute{
|
|
\textsuperscript{1}University of Example,
|
|
\textsuperscript{2}Research Institute
|
|
}
|
|
|
|
% With contact
|
|
\author{Jane Smith\textsuperscript{1,*}}
|
|
\institute{
|
|
\textsuperscript{1}Department, University\\
|
|
\textsuperscript{*}jane.smith@university.edu
|
|
}
|
|
```
|
|
|
|
### Introduction/Background
|
|
|
|
**Purpose**: Establish context, motivate research, state objective
|
|
|
|
**Structure** (50-100 words):
|
|
1. **Problem statement** (1-2 sentences): What's the issue?
|
|
2. **Knowledge gap** (1-2 sentences): What's unknown/unsolved?
|
|
3. **Research objective** (1 sentence): What did you do?
|
|
|
|
**Example** (95 words):
|
|
```
|
|
Antibiotic resistance causes 700,000 deaths annually, projected to reach
|
|
10 million by 2050. Current diagnostic methods require 48-72 hours,
|
|
delaying appropriate treatment. Machine learning offers potential for
|
|
rapid resistance prediction, but existing models lack generalizability
|
|
across bacterial species.
|
|
|
|
We developed a transformer-based deep learning model to predict antibiotic
|
|
resistance from genomic sequences across multiple pathogen species. Our
|
|
approach integrates evolutionary information and protein structure to
|
|
improve cross-species accuracy.
|
|
```
|
|
|
|
**Visual Support**:
|
|
- Conceptual diagram showing problem
|
|
- Infographic with statistics
|
|
- Image of application context
|
|
|
|
**Common Mistakes**:
|
|
- ❌ Extensive literature review
|
|
- ❌ Too much background detail
|
|
- ❌ Undefined acronyms at first use
|
|
- ❌ Missing clear objective statement
|
|
|
|
### Methods
|
|
|
|
**Purpose**: Describe approach sufficiently for understanding (not replication)
|
|
|
|
**Key Question**: "How did you do it?" not "How could someone else replicate it?"
|
|
|
|
**Content Strategy**:
|
|
- **Prioritize**: Visual methods diagram > text description
|
|
- **Include**: Study design, key procedures, analysis approach
|
|
- **Omit**: Detailed protocols, routine procedures, specific reagent details
|
|
|
|
**Visual Methods (Highly Recommended)**:
|
|
```latex
|
|
% Flowchart of study design
|
|
\begin{tikzpicture}[node distance=2cm]
|
|
\node (start) [box] {Data Collection\\n=1,000 samples};
|
|
\node (process) [box, below of=start] {Preprocessing\\Quality Control};
|
|
\node (analysis) [box, below of=process] {Statistical Analysis\\Mixed Models};
|
|
\node (end) [box, below of=analysis] {Validation\\Independent Cohort};
|
|
|
|
\draw [arrow] (start) -- (process);
|
|
\draw [arrow] (process) -- (analysis);
|
|
\draw [arrow] (analysis) -- (end);
|
|
\end{tikzpicture}
|
|
```
|
|
|
|
**Text Methods** (50-150 words):
|
|
|
|
**For Experimental Studies**:
|
|
```
|
|
Methods
|
|
• Study design: Randomized controlled trial (n=200)
|
|
• Participants: Adults aged 18-65 with Type 2 diabetes
|
|
• Intervention: 12-week exercise program vs. standard care
|
|
• Outcomes: HbA1c (primary), insulin sensitivity (secondary)
|
|
• Analysis: Linear mixed models, intention-to-treat
|
|
```
|
|
|
|
**For Computational Studies**:
|
|
```
|
|
Methods
|
|
• Dataset: 10,000 labeled images from ImageNet
|
|
• Architecture: ResNet-50 with custom attention mechanism
|
|
• Training: 100 epochs, Adam optimizer, learning rate 0.001
|
|
• Validation: 5-fold cross-validation
|
|
• Comparison: Baseline CNN, VGG-16, Inception-v3
|
|
```
|
|
|
|
**Format Options**:
|
|
- **Bullet points**: Quick scanning (recommended)
|
|
- **Numbered list**: Sequential procedures
|
|
- **Diagram + brief text**: Ideal combination
|
|
- **Table**: Multiple conditions or parameters
|
|
|
|
### Results
|
|
|
|
**Purpose**: Present key findings visually and clearly
|
|
|
|
**Golden Rule**: Show, don't tell
|
|
|
|
**Content Allocation**:
|
|
- **Figures**: 70-80% of Results section
|
|
- **Text**: 20-30% (brief descriptions, statistics)
|
|
|
|
**How Many Results**:
|
|
- **Ideal**: 3-5 main findings
|
|
- **Maximum**: 6-7 distinct results
|
|
- **Focus**: Primary outcomes, most impactful findings
|
|
|
|
**Figure Selection Criteria**:
|
|
1. Does it support the main message?
|
|
2. Is it self-explanatory with caption?
|
|
3. Can it be understood in 10 seconds?
|
|
4. Does it add information beyond text?
|
|
|
|
**Figure Captions**:
|
|
- **Descriptive**: Explain what is shown
|
|
- **Standalone**: Understandable without reading full poster
|
|
- **Statistical**: Include significance indicators, sample sizes
|
|
- **Concise**: 1-3 sentences
|
|
|
|
**Example Caption**:
|
|
```latex
|
|
\caption{Treatment significantly improved outcomes.
|
|
Mean±SD shown for control (blue, n=45) and treatment (orange, n=47) groups.
|
|
**p<0.01, ***p<0.001 (two-tailed t-test).}
|
|
```
|
|
|
|
**Text Support for Results** (100-200 words):
|
|
- State main finding per figure
|
|
- Include key statistics
|
|
- Note trends or patterns
|
|
- Avoid detailed interpretation (save for Discussion)
|
|
|
|
**Example Results Text**:
|
|
```
|
|
Key Findings
|
|
• Model achieved 87% accuracy on test set (vs. 73% baseline)
|
|
• Performance consistent across 5 bacterial species (p<0.001)
|
|
• Prediction speed: <30 seconds per isolate
|
|
• Feature importance: protein structure (42%), sequence (35%),
|
|
evolutionary conservation (23%)
|
|
```
|
|
|
|
**Data Presentation Formats**:
|
|
|
|
**1. Bar Charts**: Comparing categories
|
|
```latex
|
|
\begin{tikzpicture}
|
|
\begin{axis}[
|
|
ybar,
|
|
ylabel=Accuracy (\%),
|
|
symbolic x coords={Baseline, Model A, Our Method},
|
|
xtick=data,
|
|
nodes near coords
|
|
]
|
|
\addplot coordinates {(Baseline,73) (Model A,81) (Our Method,87)};
|
|
\end{axis}
|
|
\end{tikzpicture}
|
|
```
|
|
|
|
**2. Line Graphs**: Trends over time
|
|
**3. Scatter Plots**: Correlations
|
|
**4. Heatmaps**: Matrix data, clustering
|
|
**5. Box Plots**: Distributions, comparisons
|
|
**6. ROC Curves**: Classification performance
|
|
|
|
### Discussion/Conclusions
|
|
|
|
**Purpose**: Interpret findings, state implications, acknowledge limitations
|
|
|
|
**Structure** (100-150 words):
|
|
|
|
**1. Main Conclusions** (50-75 words):
|
|
- 3-5 bullet points
|
|
- Clear, specific takeaways
|
|
- Linked to research objectives
|
|
|
|
**Example**:
|
|
```
|
|
Conclusions
|
|
• First cross-species model for antibiotic resistance prediction
|
|
achieving >85% accuracy
|
|
• Protein structure integration critical for generalizability
|
|
(improved accuracy by 14%)
|
|
• Prediction speed enables clinical decision support within
|
|
consultation timeframe
|
|
• Potential to reduce inappropriate antibiotic use by 20-30%
|
|
```
|
|
|
|
**2. Limitations** (25-50 words, optional but recommended):
|
|
- Acknowledge key constraints
|
|
- Brief, honest
|
|
- Shows scientific rigor
|
|
|
|
**Example**:
|
|
```
|
|
Limitations
|
|
• Training data limited to 5 bacterial species
|
|
• Requires genomic sequencing (not widely available)
|
|
• Validation needed in prospective clinical trials
|
|
```
|
|
|
|
**3. Future Directions** (25-50 words, optional):
|
|
- Next steps
|
|
- Broader implications
|
|
- Call to action
|
|
|
|
**Example**:
|
|
```
|
|
Next Steps
|
|
• Expand to 20+ additional species
|
|
• Develop point-of-care sequencing integration
|
|
• Launch multi-center clinical validation study (2025)
|
|
```
|
|
|
|
**Avoid**:
|
|
- ❌ Overstating findings: "This revolutionary breakthrough..."
|
|
- ❌ Extensive comparison to other work
|
|
- ❌ New results in Discussion
|
|
- ❌ Vague conclusions: "Further research is needed"
|
|
|
|
### References
|
|
|
|
**How Many**: 5-10 key citations
|
|
|
|
**Selection Criteria**:
|
|
- Include seminal work in the field
|
|
- Recent relevant studies (last 5 years)
|
|
- Methods cited in your poster
|
|
- Controversial claims that need support
|
|
|
|
**Format**: Abbreviated, consistent style
|
|
|
|
**Examples**:
|
|
|
|
**Numbered (Vancouver)**:
|
|
```
|
|
References
|
|
1. Smith et al. (2023). Nature. 615:234-240.
|
|
2. Jones & Lee (2024). Science. 383:112-118.
|
|
3. Chen et al. (2022). Cell. 185:456-470.
|
|
```
|
|
|
|
**Author-Year (APA)**:
|
|
```
|
|
References
|
|
Smith, J. et al. (2023). Title. Nature, 615, 234-240.
|
|
Jones, A., & Lee, B. (2024). Title. Science, 383, 112-118.
|
|
```
|
|
|
|
**Minimal (For Space Constraints)**:
|
|
```
|
|
Key References: Smith (Nature 2023), Jones (Science 2024),
|
|
Chen (Cell 2022). Full bibliography: [QR Code]
|
|
```
|
|
|
|
**Alternative**: QR code linking to full reference list
|
|
|
|
### Acknowledgments
|
|
|
|
**Include**:
|
|
- Funding sources (with grant numbers)
|
|
- Major collaborators
|
|
- Core facilities used
|
|
- Dataset sources
|
|
|
|
**Format** (25-50 words):
|
|
```
|
|
Acknowledgments
|
|
Funded by NIH Grant R01-123456 and NSF Award 7890123.
|
|
We thank Dr. X for data access, the Y Core Facility for
|
|
sequencing, and Z for helpful discussions.
|
|
```
|
|
|
|
### Contact Information
|
|
|
|
**Essential Elements**:
|
|
- Name of presenting/corresponding author
|
|
- Email address
|
|
- Optional: Lab website, Twitter/X, LinkedIn, ORCID
|
|
|
|
**Format**:
|
|
```
|
|
Contact: Jane Smith, jane.smith@university.edu
|
|
Lab: smithlab.university.edu | Twitter: @smithlab
|
|
```
|
|
|
|
**QR Code Alternative**:
|
|
- Link to personal/lab website
|
|
- Link to paper preprint/publication
|
|
- Link to code repository (GitHub)
|
|
- Link to supplementary materials
|
|
|
|
## Writing Style for Posters
|
|
|
|
### Active vs. Passive Voice
|
|
|
|
**Prefer Active Voice** (more engaging, clearer):
|
|
- ✅ "We developed a model..."
|
|
- ✅ "The treatment reduced symptoms..."
|
|
|
|
**Passive Voice** (when appropriate):
|
|
- ✅ "Samples were collected from..."
|
|
- ✅ "Data were analyzed using..."
|
|
|
|
### Sentence Length
|
|
|
|
**Keep Sentences Short**:
|
|
- **Ideal**: 10-15 words per sentence
|
|
- **Maximum**: 20-25 words
|
|
- **Avoid**: >30 words (hard to follow)
|
|
|
|
**Example Revision**:
|
|
- ❌ Long: "We performed a comprehensive analysis of gene expression data from 500 patients with colorectal cancer using RNA sequencing and identified 47 differentially expressed genes associated with treatment response." (31 words)
|
|
- ✅ Short: "We analyzed RNA sequencing data from 500 colorectal cancer patients. We identified 47 genes associated with treatment response." (19 words total, two sentences)
|
|
|
|
### Bullet Points vs. Paragraphs
|
|
|
|
**Use Bullet Points For**:
|
|
- ✅ Lists of items or findings
|
|
- ✅ Key conclusions
|
|
- ✅ Methods steps
|
|
- ✅ Study characteristics
|
|
|
|
**Use Short Paragraphs For**:
|
|
- ✅ Narrative flow (Introduction)
|
|
- ✅ Complex explanations
|
|
- ✅ Connected ideas
|
|
|
|
**Bullet Point Best Practices**:
|
|
- Start with action verbs or nouns
|
|
- Parallel structure throughout list
|
|
- 3-7 bullets per list (not too many)
|
|
- Brief (1-2 lines each)
|
|
|
|
**Example**:
|
|
```
|
|
Methods
|
|
• Participants: 200 adults (18-65 years)
|
|
• Design: Double-blind RCT (12 weeks)
|
|
• Intervention: Daily 30-min exercise
|
|
• Control: Standard care
|
|
• Analysis: Mixed models (SPSS v.28)
|
|
```
|
|
|
|
### Acronyms and Jargon
|
|
|
|
**First Use Rule**: Define at first appearance
|
|
```
|
|
We used machine learning (ML) to analyze... Later, ML predicted...
|
|
```
|
|
|
|
**Common Acronyms**: May not need definition if universal to field
|
|
- DNA, RNA, MRI, CT, PCR (in biomedical context)
|
|
- AI, ML, CNN (in computer science context)
|
|
|
|
**Avoid Excessive Jargon**:
|
|
- ❌ "Utilized" → ✅ "Used"
|
|
- ❌ "Implement utilization of" → ✅ "Use"
|
|
- ❌ "A majority of" → ✅ "Most"
|
|
|
|
### Numbers and Statistics
|
|
|
|
**Present Statistics Clearly**:
|
|
- Always include measure of variability (SD, SE, CI)
|
|
- Report sample sizes: n=50
|
|
- Indicate significance: p<0.05, p<0.01, p<0.001
|
|
- Use symbols consistently: * for p<0.05, ** for p<0.01
|
|
|
|
**Format Numbers**:
|
|
- Round appropriately (avoid false precision)
|
|
- Use consistent decimal places
|
|
- Include units: 25 mg/dL, 37°C
|
|
- Large numbers: 1,000 or 1000 (be consistent)
|
|
|
|
**Example**:
|
|
```
|
|
Treatment increased response by 23.5% (95% CI: 18.2-28.8%, p<0.001, n=150)
|
|
```
|
|
|
|
## Visual-Text Integration
|
|
|
|
### Figure-Text Relationship
|
|
|
|
**Figure First, Text Second**:
|
|
1. Design poster around key figures
|
|
2. Add text to support and explain visuals
|
|
3. Ensure figures can stand alone
|
|
|
|
**Text Placement Relative to Figures**:
|
|
- **Above**: Context, "What you're about to see"
|
|
- **Below**: Explanation, statistics, caption
|
|
- **Beside**: Comparison, interpretation
|
|
|
|
### Callouts and Annotations
|
|
|
|
**On-Figure Annotations**:
|
|
```latex
|
|
\begin{tikzpicture}
|
|
\node[inner sep=0] (img) {\includegraphics[width=10cm]{figure.pdf}};
|
|
\draw[->, thick, red] (8,5) -- (6,3) node[left] {Key region};
|
|
\draw[red, thick] (3,2) circle (1cm) node[above=1.2cm] {Anomaly};
|
|
\end{tikzpicture}
|
|
```
|
|
|
|
**Callout Boxes**:
|
|
```latex
|
|
\begin{tcolorbox}[colback=yellow!10, colframe=orange!80,
|
|
title=Key Finding]
|
|
Our method reduces errors by 34\% compared to state-of-the-art.
|
|
\end{tcolorbox}
|
|
```
|
|
|
|
### Icons for Section Headers
|
|
|
|
**Visual Section Markers**:
|
|
```latex
|
|
\usepackage{fontawesome5}
|
|
|
|
\block{\faFlask~Introduction}{...}
|
|
\block{\faCog~Methods}{...}
|
|
\block{\faChartBar~Results}{...}
|
|
\block{\faLightbulb~Conclusions}{...}
|
|
```
|
|
|
|
## Content Adaptation Strategies
|
|
|
|
### From Paper to Poster
|
|
|
|
**Condensation Process**:
|
|
|
|
**1. Identify Core Message** (The Elevator Pitch):
|
|
- What's the one thing you want people to remember?
|
|
- If you had 30 seconds, what would you say?
|
|
|
|
**2. Select Key Results**:
|
|
- Choose 3-5 most impactful findings
|
|
- Omit supporting/secondary results
|
|
- Focus on figures with strong visual impact
|
|
|
|
**3. Simplify Methods**:
|
|
- Visual flowchart > text description
|
|
- Omit routine procedures
|
|
- Include only essential parameters
|
|
|
|
**4. Trim Literature Review**:
|
|
- One sentence background
|
|
- One sentence gap/motivation
|
|
- One sentence your contribution
|
|
|
|
**5. Condense Discussion**:
|
|
- Main conclusions only
|
|
- Brief limitations
|
|
- One sentence future direction
|
|
|
|
### For Different Audiences
|
|
|
|
**Specialist Audience** (Same Field):
|
|
- Can use field-specific jargon
|
|
- Less background needed
|
|
- Focus on novel methodology
|
|
- Emphasize nuanced findings
|
|
|
|
**General Scientific Audience**:
|
|
- Define key terms
|
|
- More context/background
|
|
- Broader implications
|
|
- Visual metaphors helpful
|
|
|
|
**Public/Lay Audience**:
|
|
- Minimal jargon, all defined
|
|
- Extensive context
|
|
- Real-world applications
|
|
- Analogies and simple language
|
|
|
|
**Example Adaptation**:
|
|
|
|
**Specialist**: "CRISPR-Cas9 knockout of BRCA1 induced synthetic lethality with PARP inhibitors"
|
|
|
|
**General**: "We used gene editing to make cancer cells vulnerable to existing drugs"
|
|
|
|
**Public**: "We found a way to make cancer treatments work better by targeting specific genetic weaknesses"
|
|
|
|
## Quality Control Checklist
|
|
|
|
### Content Review
|
|
|
|
**Clarity**:
|
|
- [ ] Main message immediately clear
|
|
- [ ] All acronyms defined
|
|
- [ ] Sentences short and direct
|
|
- [ ] No unnecessary jargon
|
|
|
|
**Completeness**:
|
|
- [ ] Research question/objective stated
|
|
- [ ] Methods sufficiently described
|
|
- [ ] Key results presented
|
|
- [ ] Conclusions drawn
|
|
- [ ] Limitations acknowledged
|
|
|
|
**Accuracy**:
|
|
- [ ] All statistics correct
|
|
- [ ] Figure captions accurate
|
|
- [ ] References properly cited
|
|
- [ ] No overstated claims
|
|
|
|
**Engagement**:
|
|
- [ ] Compelling title
|
|
- [ ] Visual interest
|
|
- [ ] Clear take-home message
|
|
- [ ] Conversation starters
|
|
|
|
### Readability Testing
|
|
|
|
**Distance Test**:
|
|
- Print at 25% scale
|
|
- View from 2-3 feet (simulates 8-12 feet for full poster)
|
|
- Can you read: Title? Section headers? Body text?
|
|
|
|
**Scan Test**:
|
|
- Give poster to colleague for 30 seconds
|
|
- Ask: "What is this poster about?"
|
|
- They should identify: Topic, approach, main finding
|
|
|
|
**Detail Test**:
|
|
- Ask colleague to read poster thoroughly (5 min)
|
|
- Ask: "What are the key conclusions?"
|
|
- Verify understanding matches your intent
|
|
|
|
## Common Content Mistakes
|
|
|
|
**1. Too Much Text**
|
|
- ❌ >1000 words
|
|
- ❌ Long paragraphs
|
|
- ❌ Full paper condensed
|
|
- ✅ 300-800 words, bullet points, key findings only
|
|
|
|
**2. Unclear Message**
|
|
- ❌ Multiple unrelated findings
|
|
- ❌ No clear conclusion
|
|
- ❌ Vague implications
|
|
- ✅ 1-3 main points, explicit conclusions
|
|
|
|
**3. Methods Overkill**
|
|
- ❌ Detailed protocols
|
|
- ❌ All parameters listed
|
|
- ❌ Routine procedures described
|
|
- ✅ Visual flowchart, key details only
|
|
|
|
**4. Poor Figure Integration**
|
|
- ❌ Figures without context
|
|
- ❌ Unclear captions
|
|
- ❌ Text doesn't reference figures
|
|
- ✅ Figures central, well-captioned, text integrated
|
|
|
|
**5. Missing Context**
|
|
- ❌ No background
|
|
- ❌ Undefined acronyms
|
|
- ❌ Assumes expert knowledge
|
|
- ✅ Brief context, definitions, accessible to broader audience
|
|
|
|
## Conclusion
|
|
|
|
Effective poster content:
|
|
- **Concise**: 300-800 words maximum
|
|
- **Visual**: 40-50% figures and graphics
|
|
- **Clear**: One main message, 3-5 key findings
|
|
- **Engaging**: Compelling story, not just facts
|
|
- **Accessible**: Appropriate for target audience
|
|
- **Actionable**: Clear implications and next steps
|
|
|
|
Remember: Your poster is a conversation starter, not a comprehensive treatise. Design content to intrigue, engage, and invite discussion.
|
|
|